MedTrace Logo

Zinc Supplementation in Cirrhotic Patients

NCT02475928 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2019-02-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of zinc supplementation in the treatment for dysgeusia, progression disease and quality of life in patients with liver cirrhosis.

Conditions

Interventions

DIETARY_SUPPLEMENT

zinc gluconate

Zinc supplementation plus nutritional education

DIETARY_SUPPLEMENT

Placebo

BEHAVIORAL

Nutritional education

Sponsors & Collaborators

  • Fundación Clínica Médica Sur

    lead OTHER

Principal Investigators

  • Norberto C Chávez-Tapia, PhD · Medica Sur Clinic & Foundation

  • Eva Juárez-Hernández · Medica Sur Clinic & Foundation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02475928 on ClinicalTrials.gov